FCR (Fludarabine, Cyclophosphamide, Rituximab) regimen followed by (90)yttrium ibritumomab tiuxetan consolidation for the treatment of relapsed grades 1 and 2 follicular lymphoma: a report of 9 cases

BACKGROUND: This retrospective analysis is focused on the efficacy and safety of radioimmunotherapy (RIT) with Zevalin(® )in nine patients with recurrent follicular lymphoma (FL) who were treated in a consolidation setting after having achieved complete remission or partial remission with FCR. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Pisani, Francesco, Maini, Carlo Ludovico, Sciuto, Rosa, Dessanti, Laura, D'Andrea, Mariella, Assisi, Daniela, Petti, Maria Concetta
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3041690/
https://www.ncbi.nlm.nih.gov/pubmed/21303501
http://dx.doi.org/10.1186/1756-9966-30-16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3041690/
https://www.ncbi.nlm.nih.gov/pubmed/21303501
http://dx.doi.org/10.1186/1756-9966-30-16

Ejemplares similares